Volume 95 Issue 47 | p. 13 | Concentrates
Issue Date: November 27, 2017

Boehringer provides access to molecules

Department: Business
Keywords: Drug discovery, open access, small molecules, Boehringer Ingelheim

Boehringer Ingelheim has begun offering outside scientists free access to select preclinical molecules for nonclinical investigation on an online platform called opnME.com. Most molecules are offered without intellectual property agreements. Boehringer is also offering a crowdsourcing service on the site through which scientists submit proposals for projects that can be developed with the company’s researchers. The platform follows other moves at the firm to promote collaboration, including Research Beyond Borders, a research partnership initiative, and the Boehringer Ingelheim Venture Fund.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment